Bioactive Terpenoid Compounds in Medicinal Applications

Terpenoid compounds represent one of the largest and most structurally diverse classes of natural products, encompassing mono-, sesqui-, di-, and triterpenoids. Their broad therapeutic potential spans anti-inflammatory, immunosuppressive, anticancer and antimicrobial activities. Advances in isolation and characterisation techniques have unveiled novel scaffolds such as sesquiterpene pyridine alkaloids and abietane-type diterpenoids, which modulate key signalling pathways and cellular targets. Optimisation through semi-synthetic derivatisation and total synthesis has improved potency, selectivity and pharmacokinetic profiles. Interdisciplinary efforts now integrate genomics, metabolic engineering and structure-based design to harness terpenoid biosynthesis in microbial platforms. Despite challenges in supply and formulation, bioactive terpenoids continue to inspire the development of next-generation therapeutics.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Research from all publishers

Recent studies have characterised a series of new sesquiterpene pyridine alkaloids isolated from the roots of Tripterygium wilfordii, several of which demonstrate potent inhibition of the NF-κB pathway in immune cells without compromising viability. These compounds provide promising leads for anti-inflammatory and immunomodulatory drug development, underscoring the therapeutic relevance of integrating advanced spectroscopic elucidation with cellular assays.

In parallel, comprehensive investigations into the total alkaloid fraction of T. wilfordii have identified multiple immunosuppressive sesquiterpene pyridine alkaloids capable of down-regulating pro-inflammatory cytokine production in lipopolysaccharide-stimulated macrophage models. These findings reveal structure–activity relationships that can guide medicinal chemistry efforts towards selective immunosuppressants with reduced off-target effects.

Beyond alkaloids, novel abietane and kaurane type diterpenoids extracted from traditional medicinal plants have been shown to exhibit selective cytotoxicity against human cancer cell lines, including ovarian and hepatocellular carcinomas. The discovery of unique lactone-bridged ring systems in these diterpenoids expands the chemical diversity available for anticancer lead optimisation and highlights the continued value of systematic phytochemical exploration.

Bioactive Terpenoid Compounds in Medicinal Applications publication trend

The graph below shows the total number of articles in bioactive terpenoid compounds in medicinal applications across all publications each year (not limited to Nature Index journals).

Technical terms

Terpenoid: A large class of naturally occurring organic compounds constructed from isoprene units, widely distributed in plants and microorganisms, with diverse biological activities.

Sesquiterpene pyridine alkaloid: A subclass of terpenoids in which a three-isoprene (C15) sesquiterpene core is linked to a pyridine moiety, often conferring immunomodulatory or anti-inflammatory properties.

Nuclear factor-kappa B (NF-κB): A transcription factor complex central to the regulation of immune and inflammatory responses; its dysregulation is implicated in autoimmune diseases and cancer.

Diterpenoid: A terpenoid comprising four isoprene units (C20) that can form diverse scaffolds such as abietane and kaurane, many of which exhibit cytotoxic or antimicrobial effects.

References

1. Structure Characterization of Four New Sesquiterpene Pyridine Alkaloids from Tripterygium wilfordii Hook. f. and Anti-Inflammatory Activity Evaluations. Molecules (2024).
2. Immunosuppressive Sesquiterpene Pyridine Alkaloids from Tripterygium wilfordii Hook. f.. Molecules (2022).
3. New Abietane and Kaurane Type Diterpenoids from the Stems of Tripterygium regelii. International Journal of Molecular Sciences (2017).